Careers  |  Sign In  |  Register  |   Twitter

Latest in Rheumatology

NEW YORK (Reuters Health) – Patients with rheumatoid arthritis (RA) who are prescribed statin therapy for hypercholesterolemia or ischemic heart disease are at increased risk of death from cardiovascular disease or any cause if they stop taking the medication, according to a Canadian study. The findings...

Reuters Health • The Doctor's Channel Daily Newscast

Golimumab continues effective, safe for psoriatic arthritis over a year

NEW YORK (Reuters Health) – Golimumab, a new anti-TNF monoclonal antibody, administered subcutaneously every 4 weeks, shows sustained efficacy in reducing signs and symptoms of active psoriatic arthritis through 52 weeks. The findings come from a continuation of the GO-REVEAL trial, for which earlier...

Reuters Health • The Doctor's Channel Daily Newscast

Anakinra effective in treating neonatal-onset multisystem inflammatory disease

NEW YORK (Reuters Health) – Anakinra is highly effective in treating patients with neonatal-onset multisystem inflammatory disease (NOMID), researchers from the National Institutes of Health report in the January 31st online Arthritis & Rheumatism. “NOMID/CINCA is part of a disease spectrum of...